Editor-in-Chief: Horowitz, Michal
Editorial Board Member: Das, Kusal K. / Devor, Marshall / Epstein, Yoram / S. Gershon MD, Elliot / Haim, Abraham / Kohen, Ron / Lichtstein, David / Maloyan, Alina / Mechoulam, Raphael / Shohami, Esther / Sohmer, Haim / Yoshikawa, Toshikazu / Ilani, Asher / Ringel, Israel / Youdim, Moussa B.H.
4 Issues per year
Volume 23 (2012)
Volume 22 (2011)
Volume 21 (2010)
Volume 20 (2009)
Volume 19 (2008)
Volume 18 (2007)
Volume 17 (2006)
Volume 16 (2005)
Volume 14 (2003)
Volume 13 (2002)
Volume 12 (2001)
Volume 11 (2000)
Volume 10 (1999)
Volume 8 (1997)
Volume 7 (1996)
Volume 6 (1995)
Volume 4 (1993)
Volume 3 (1992)
Volume 2-3 (1992)
Volume 2 (1991)
Volume 1 (1990)
Most Downloaded Articles
- Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder by Mirunalini , S. and Krishnaveni , M.
- The Role of Free Radicals in Toxicity and Disease by Stohs , Sidney J.
- Israeli Society for Auditory Research (ISAR): 2012 Annual Scientific Conference
- EFFECT OF TETRAHYDROCURCUMIN ON BLOOD GLUCOSE, PLASMA INSULIN AND HEPATIC KEY ENZYMES IN STREPTOZOTOCIN INDUCED DIABETIC RATS by Pari , Leelavinothan and Murugan , Pidaran
Evaluation of antidepressant activity of ropinirole coadministered with fluoxetine in acute and chronic behavioral models of depression in rats
1Glaxosmithkline, Mumbai, India
2Department of Pharmacology and Therapeutics, Seth GS Medical College and KEM Hospital, Parel, Mumbai, India
3Department of Pharmacology, TN Medical College and Nair Hospital, Mumbai, India
Citation Information: Journal of Basic and Clinical Physiology and Pharmacology. Volume 22, Issue 4, Pages 109–114, ISSN (Online) 2191-0286, ISSN (Print) 0792-6855, DOI: 10.1515/JBCPP.2011.027, November 2011
- Published Online:
Background: Certain unknown aspects of ropinirole action, such as its antidepressant effect after chronic administration and on cotreatment with fluoxetine, remain to be evaluated, which formed the rationale for this study.
Methods: Wistar rats of either sex (weighing 150–200 g) were used. In the dose-finding study, oral dose of ropinirole (20 mg/kg) was selected. This was combined with two different doses of fluoxetine (10 and 20 mg/kg). Their antidepressant-like effects were compared in acute and chronic forced-swim test (FST). Acute FST was conducted in two sessions after administration of three doses within 24 h. Chronic FST was conducted over 14 days. Drugs were administered each day for 14 days. Effect on locomotor activity was tested in OFT.
Results: ANOVA with post hoc Tukey test was used. Dose-finding study of ropinirole showed that out of three doses, 20 mg/kg produced maximum reduction in immobility in acute FST (137±8 s). Coadministration of ropinirole with fluoxetine in acute FST further reduced immobility (107±8 s). This effect was more prominent in chronic forced-swim-stressed rats (74±2 s). Neither ropinirole nor its coadministration with fluoxetine increased locomotor activity in open-field test.
Conclusions: The potential of ropinirole to act as an antidepressant agent is proven by the reduction in immobility time in FST. Further, there is an augmentation of the effect of fluoxetine by ropinirole, suggesting synergistic interaction of dopamine and serotonin pathway in brain.